Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

May 24, 2021

Yale will be second anchor tenant in new bioscience tower; Construction to begin June 7 

IMAGE | CONTRIBUTED Rendering of 101 College Street project developed by Elkus Manfredi Architects of Boston.
By Natalie Missakian

Yale University said it has leased 125,000 square feet in a new bioscience tower planned for downtown. 

The university is also throwing its financial support behind a new life sciences incubator to be housed there for fledgling startups.  

In a statement, Yale officials said the university plans to occupy three floors of office and lab space in the building, which is being built by Massachusetts developer Carter Winstanley. 

Meanwhile, BioLabs, a Cambridge-based company that specializes in managing co-working space for life science startups, will run the new 48,000-square-foot Yale-backed incubator.

BioLabs describes itself as a “national, membership-based network of shared lab and office facilities located in key biotech innovation clusters,” according to its website.

It has eight other locations, including in Boston, New York, Philadelphia, Los Angeles and Durham, North Carolina.  

The incubator will serve startups from around the state, including companies spun out of research at UConn and other institutions, according to Yale. Yale said it will allow New Haven biotech startups to remain close to the university’s research facilities. 

“Improving our STEM entrepreneur and innovation ecosystem, including our core facilities, are central tenets of our university science strategy,” said Yale Provost Scott Strobel in a statement. “Our investment in 101 College Street attends to those and many other future needs.”

Yale had long been expected to become a tenant in the building, but the university officially announced the lease at the Yale Innovation Summit Friday afternoon, during a panel discussion on the future of biotech in New Haven.

The university said the leased space will remain on the city tax rolls. Yale would not disclose financial terms of the lease or say how much it is investing in the incubator. 

Yale will join growing New Haven biotech Arvinas Inc. in anchoring the building. Arvinas, a company spun out of Yale, announced earlier this month that it will lease 160,000 square feet on three floors of the new tower.

The new 10-story, 525,000-square-foot building is slated to go up across from an earlier Winstanley bioscience development at 100 College St, which currently houses Alexion Pharmaceuticals. The Alexion building is also slated to house a planned Yale neuroscience center.

Both buildings are located near Yale’s medical school and Yale New Haven Hospital, and are part of the city’s Downtown Crossing revitalization project, which aims to reconnect the medical district with downtown. 

Officials are planning to break ground on 101 College St. on June 7 at 1 p.m..  Construction is expected to take around two years.

Contact Natalie Missakian at news@newhavenbiz.com

This story has been updated

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF